Patents by Inventor Pauliina Lehtolainen

Pauliina Lehtolainen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biotin-binding receptor molecules
    Publication number: 20090011984
    Abstract: The subject invention pertains to a transmembrane protein capable of binding to biotinylated molecules, the protein comprising a cytoplasmic domain, a membrane-spanning domain and an extracellular domain, wherein the extracellular domain comprises biotin-binding activity, and methods of use. The protein can be expressed in a cell, thereby targeting a biotinylated drug.
    Type: Application
    Filed: April 24, 2007
    Publication date: January 8, 2009
    Inventors: Seppo Yla-Herttuala, Markku Kulomaa, Pauliina Lehtolainen, Varpu Marjomaki, Kari Airenne
  • Nucleic acids encoding biotin-binding receptors
    Patent number: 7208291
    Abstract: The present invention pertains to a novel transmembrane protein capable of binding to biotinylated molecules, the protein comprising a cytoplasmic domain, a membrane-spanning domain and an extracellular domain, wherein the extracellular domain comprises biotin-binding activity.
    Type: Grant
    Filed: July 11, 2003
    Date of Patent: April 24, 2007
    Assignee: Ark Therapeutics Limited
    Inventors: Seppo Yla-Herttuala, Markku Kulomaa, Pauliina Lehtolainen, Varpu Marjomaki, Kari Airenne
  • Gene delivery of a viral vector
    Publication number: 20040208905
    Abstract: A baculovirus is used for gene therapy of a condition that can be mediated via the spinal cord or CNS.
    Type: Application
    Filed: April 29, 2004
    Publication date: October 21, 2004
    Inventors: Seppo Yla-Herttuala, Kari Juhani Airenne, Pauliina Lehtolainen
  • Biotin-binding receptor molecules
    Publication number: 20040185059
    Abstract: The present invention pertains to a novel transmembrane protein capable of binding to biotinylated molecules, the protein comprising a cytoplasmic domain, a membrane-spanning domain and an extracellular domain, wherein the extracellular domain comprises biotin-binding activity.
    Type: Application
    Filed: July 11, 2003
    Publication date: September 23, 2004
    Inventors: Seppo Yla-Herttuala, Markku Kulomaa, Pauliina Lehtolainen, Varpu Marjomaki, Kari Airenne